Changchun GeneScience Pharmaceutical Co., Ltd. (“GenSci”), founded in 1996, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd (stock code 000661). Its administrative headquarters and manufacturing sites are located in Changchun...

At present, GenSci has more than 16 projects in the preclinical stage, and 8 projects are undergoing clinical stage. Therapeutic fields include growth and development, assisted reproduction, tumor, immune, antiviral and metabolic diseases, etc.

GenSci is China's “demonstrationcenter for quality control of genetically engineered pharmaceuticals” and “the national incubation site of novel genetically engineered medicines.” Through 25 years of exploration, GenSci has built a national pilot incubation base for new genetically engineered drugs.

Established in 1996, Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as ‘‘GenSci’) is one of the holding subsidiaries of Changchun High-tech (SZSE 000661)

Established in 1996, Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as ‘‘GenSci’) is one of the holding subsidiaries of Changchun High-tech (SZSE 000661)

GenSci059 was granted for clinical trial license by NMPA in September 2020 and Study May Proceed by US FDA in December 2020. It is deemed a milestone marked GenSci’s R&D project in conformity to international...

Established in 1996, Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as ‘‘GenSci’) is one of the holding subsidiaries of Changchun High-tech (SZSE 000661)

2021年9月10日 · On December 18, 2020, Beijing time, GenSci’s Gentulizumab R&D project was approved by the US FDA for clinical trials, which means that this innovative therapy will soon proceed to clinical research in the United States.

Established in 1996, Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as ‘‘GenSci’) is one of the holding subsidiaries of Changchun High-tech (SZSE 000661)

Established in 1996, Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as ‘‘GenSci’) is one of the holding subsidiaries of Changchun High-tech (SZSE 000661)